Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
A clinical trial update indicates a study evaluating chemotherapy combined with immunotherapy for HER2 insertion or amplification in advance…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
A clinical trial update indicates a recruiting study at Union Hospital, Tongji Medical College, Huazhong University of Science and Technolog…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB [Phase 2]
A Phase 2 trial evaluating atezolizumab plus platinum-based chemotherapy as neoadjuvant therapy for resectable stage II-IIIB non-small cell …
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC [Phase 2]
A Phase 2 clinical trial is evaluating furmonertinib in combination as neoadjuvant therapy for resectable EGFR-mutated non-small cell lung c…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial [NA]
This entry reports on a single-arm, open-label trial evaluating almonertinib in combination with stereotactic body radiotherapy for EGFR-mut…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer [NA]
This clinical trial update reports that the study evaluating adding activity monitoring with a wearable device to patient care during lung c…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer [NA]
A clinical trial is evaluating cryoablation with or without serplulimab for Stage I-IIA non-small cell lung cancer; the study is not yet rec…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is evaluating stereotactic body radiotherapy for oligoprogression in metastatic non-small cell lung cancer and is c…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations [Phase 2]
A Phase 2 clinical trial is evaluating the combination of lenvatinib with carboplatin, pemetrexed, and pembrolizumab for EGFR-mutant non-sma…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis [Phase 2]
A Phase 2 clinical trial from Fudan University evaluates cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis [Phase 2]
A Phase 2 clinical trial update on cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation negative non-small ce…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Perioperative Immunotherapy for NSCLC (ECTOP-1030) [Phase 2]
Phase 2 clinical trial update for perioperative immunotherapy in non-small cell lung cancer (ECTOP-1030), currently not yet recruiting; spon…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)
This update notes an ongoing clinical trial in Italy investigating the incidence and characterization of driver oncogenes in patients with N…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC
A clinical trial is evaluating nintedanib for preventing radiation pneumonitis in patients with unresectable non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer [Phase 2]
Betta Pharmaceuticals is updating a Phase 2 clinical trial evaluating Befotertinib and Icotinib in treatment-naive patients with advanced EG…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: CTS2190 Phase I /II Clinical Study in Patients [Phase 1, Phase 2]
CTS2190 is a Phase 1/2 clinical study by CytosinLab Therapeutics evaluating CTS2190 in solid tumors, including pancreatic cancer, non-small …
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating ensartinib as adjuvant therapy for ALK-positive non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients [Phase 4]
Phase 4 trial updates Befotertinib as adjuvant therapy for stage IA2-IB non-small cell lung cancer; the study is currently recruiting and ex…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease [Phase 2]
Phase 2 clinical trial exploring immunotherapy combined with carbon ion radiotherapy in solid cancers with stable disease, currently recruit…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
This clinical trial update notes a study focused on evaluating liquid biopsies in patients presenting with non-small cell lung cancer. The t…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1]
RemeGen's RC198 is being evaluated in a Phase 1 study across locally advanced unresectable or metastatic solid tumors, including melanoma, u…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer [Phase 3]
Phase 3 safety and efficacy study evaluating a Bevacizumab-based combination with Paclitaxel and Carboplatin in non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial update evaluating a CSF CTC-capture-guided combination of EGFR-TKI and bevacizumab in EGFR-mutant ad…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC [Phase 2]
A Phase 2 trial is evaluating whether olanzapine may influence outcomes when combined with first-line immunotherapy in advanced EGFR-negativ…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study [Phase 1]
An ongoing Phase 1 pilot trial (PRIME_LUNG) is evaluating primary radiotherapy in metastatic non-small cell lung cancer. The study is curren…